SORT1 and ovarian carcinoma: Overall, these data confirm the cytotoxic activity of TH1902 against ES-2 and SKOV3 ovarian cancer cells, just as was previously shown against the SORT1-expressing TNBC cell line MDA-MB-231 [25].